Mark Hamelburg is a member of SNR Denton's Health Care Group in Washington, DC. Mr. Hamelburg has almost 20 years of health law experience in a variety of settings and specialties. Mr. Hamelburg's primary focus is on the Medicare Prescription Drug and Medicare Advantage programs. Prior to joining SNR Denton in 2009, Mr. Hamelburg served as Director of the Medicare Part C and Part D Analysis Group in the Office of Legislation at the Centers for Medicare & Medicaid Services (CMS) in the U.S. Department of Health & Human Services (HHS). In this capacity, he focused on legislative and regulatory matters involving the Medicare Advantage and Prescription D programs and other issues involving private health insurance. This focus included development and analyses of various legislative and regulatory proposals, technical assistance to Congressional staff, preparation of agency witnesses for testimony and strategic planning on a range of issues. As director of the Employer Policy and Operations Group at CMS, Mark led the successful development and implementation of the Retiree Drug Subsidy and employer/union waiver programs that covered more than 8.5 million beneficiaries in thousands of employer/union plans. Prior to joining CMS, Mark served as a principal in the Washington Resource Group at Mercer Human Resource Consulting, Washington, DC. In this capacity he advised clients on tax, ERISA, HIPAA and other compliance issues. (This is me - Update Profile)
G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.
Mark Hamelburg has not published any GLG News Analyses.
| Study Group Name | No. Members |
|---|---|
| Economic Experts on Managed Care | 804 |
Mark Hamelburg has not participated in any GLG Live Meetings.
View all GLG Live Meetings in Legal, Economic & Regulatory Affairs